News
We represent Sanctum Therapeutics in
merger with Adnexus Biotechnologies

Our corporate and IP lawyers represented Sanctum Therapeutics in a merger transaction that is anticipated to accelerate the development of high-impact biotechnology therapies.

Competitive edge: HSR mini-series
November 20, 2024 – November 21, 2024

In this HSR mini-series, our lawyers from different practice industries will join Neely Agin, Luke McFarland and Mark Angland to discuss key highlights surrounding the FTC's final rule.

Thought leadership

The June Project Finance NewsWire is out. We report on the rapidly developing tax credit sales market, a new US claims court decision that will affect tax equity and M&A transactions, issues in hydrogen projects, the difficulty people are having applying domestic content guidance, how wage and apprentice issues are being handled in contract negotiations and much more.